scholarly journals The Instrument Design of the DLR Earth Sensing Imaging Spectrometer (DESIS)

Sensors ◽  
2019 ◽  
Vol 19 (7) ◽  
pp. 1622 ◽  
Author(s):  
David Krutz ◽  
Rupert Müller ◽  
Uwe Knodt ◽  
Burghardt Günther ◽  
Ingo Walter ◽  
...  

Whether for identification and characterization of materials or for monitoring of theenvironment, space-based hyperspectral instruments are very useful. Hyperspectral instrumentsmeasure several dozens up to hundreds of spectral bands. These data help to reconstruct the spectralproperties like reflectance or emission of Earth surface or the absorption of the atmosphere, and toidentify constituents on land, water, and in the atmosphere. There are a lot of possible applications,from vegetation and water quality up to greenhouse gas monitoring. But the actual number ofhyperspectral space-based missions or hyperspectral space-based data is limited. This will be changedin the next years by different missions. The German Aerospace Center (DLR) Earth Sensing ImagingSpectrometer (DESIS) is one of the new currently existing space-based hyperspectral instruments,launched in 2018 and ready to reduce the gap of space-born hyperspectral data. The instrument isoperating onboard the International Space Station, using the Multi-User System for Earth Sensing(MUSES) platform. The instrument has 235 spectral bands in the wavelength range from visible(400 nm) to near-infrared (1000 nm), which results in a 2.5 nm spectral sampling distance and aground sampling distance of 30 m from 400 km orbit of the International Space Station. In this article,the design of the instrument will be described.

Author(s):  
Ralf Reulke ◽  
Ilse Sebastian ◽  
David Krutz ◽  
Andreas Eckardt ◽  
Holger Venus ◽  
...  

Author(s):  
E. Carmona ◽  
J. Avbelj ◽  
K. Alonso ◽  
M. Bachmann ◽  
D. Cerra ◽  
...  

The German Aerospace Center (DLR) and Teledyne Brown Engineering (TBE) have established a collaboration to develop and operate a new space-based hyperspectral sensor, the DLR Earth Sensing Imaging Spectrometer (DESIS). DESIS will provide spacebased hyperspectral data in the VNIR with high spectral resolution and near-global coverage. While TBE provides the platform and infrastructure for operation of the DESIS instrument on the International Space Station, DLR is responsible for providing the instrument and the processing software. The DESIS instrument is equipped with novel characteristics for an imaging spectrometer such high spectral resolution (2.55 nm), a mirror pointing unit or a CMOS sensor operated in rolling shutter mode. We present here an overview of the DESIS instrument and its processing chain, emphasizing the effect of the novel characteristics of DESIS in the data processing and final data products. Furthermore, we analyse in more detail the effect of the rolling shutter on the DESIS data and possible mitigation/correction strategies.


2005 ◽  
Author(s):  
Danielle Paige Smith ◽  
Vicky E. Byrne ◽  
Cynthia Hudy ◽  
Mihriban Whitmore

2020 ◽  
Vol 91 (1) ◽  
pp. 41-45 ◽  
Author(s):  
Virginia. E. Wotring ◽  
LaRona K. Smith

INTRODUCTION: There are knowledge gaps in spaceflight pharmacology with insufficient in-flight data to inform future planning. This effort directly addressed in-mission medication use and also informed open questions regarding spaceflight-associated changes in pharmacokinetics (PK) and/or pharmacodynamics (PD).METHODS: An iOS application was designed to collect medication use information relevant for research from volunteer astronaut crewmembers: medication name, dose, dosing frequency, indication, perceived efficacy, and side effects. Leveraging the limited medication choices aboard allowed a streamlined questionnaire. There were 24 subjects approved for participation.RESULTS: Six crewmembers completed flight data collection and five completed ground data collection before NASA’s early study discontinuation. There were 5766 medication use entries, averaging 20.6 ± 8.4 entries per subject per flight week. Types of medications and their indications were similar to previous reports, with sleep disturbances and muscle/joint pain as primary drivers. Two subjects treated prolonged skin problems. Subjects also used the application in unanticipated ways: to note drug tolerance testing or medication holiday per research protocols, and to share data with flight surgeons. Subjects also provided usability feedback on application design and implementation.DISCUSSION: The volume of data collected (20.6 ± 8.4 entries per subject per flight week) is much greater than was collected previously (<12 per person per entire mission), despite user criticisms regarding app usability. It seems likely that improvements in a software-based questionnaire application could result in a robust data collection tool that astronauts find more acceptable, while simultaneously providing researchers and clinicians with useful data.Wotring VE, Smith LK. Dose tracker application for collecting medication use data from International Space Station crew. Aerosp Med Hum Perform. 2020; 91(1):41–45.


Sign in / Sign up

Export Citation Format

Share Document